A relative increase in circulating platelets following chemoradiation predicts for poor survival of patients with glioblastoma

作者：Boonyawan Keeratikarn; Hess Kenneth R; Yang Jie; Long Lihong; Wang Qianghu; Ezhilarasan Ravesanker; Auia Alessandra; Alfaro Munoz Kristin D; de Groot John F; Bhat Krishna P; Sulman Erik P^*

来源：Oncotarget, 2017, 8(52): 90488-90495.

DOI：10.18632/oncotarget.21799

• glioblastoma
• platelets
• thrombocytosis
• prognosis
• survival
• liquid biopsy

Background: Thrombocytosis is triggered by and promotes tumor growth. The relationship between the change in circulating platelets after chemoradiation therapy (CRT) or adjuvant temozolomide (TMZ) and survival in glioblastoma remains unclear. We hypothesized that an increase in platelets after these treatments would be predictive of a shorter survival.
Methods: We retrospectively reviewed data on 122 patients with newly diagnosed, pathologically proven glioblastoma who had been treated with surgery, followed by CRT and adjuvant TMZ, from 2007 to 2016. The association between the changes in blood count levels and survival was analyzed by the log-rank test. To adjust for confounding, we performed a multivariate analysis using known prognostic co-variates.
Results: Patients were dichotomized on the basis of the relative change in platelets after CRT from the baseline: <= 30% increase, low (n = 101) vs > 30% increase, high (n = 12). The median survival for high vs. low platelets were 11 vs 28 months (p = 0.0062). No significant survival differences were observed on the basis of platelet changes during adjuvant TMZ. Similarly, changes in lymphocyte counts were not significantly prognostic. On multivariate analysis, MGMT, performance status, and an increase in platelets after CRT were significantly associated with survival (HR for platelets, 4.5; 95% confidence interval, 1.6-12.6).
Conclusions: Increased platelet counts after CRT are predictive of poor survival in glioblastoma. The effect is platelet specific and does not reflect bone marrow changes, as lymphocyte changes were not significantly prognostic. These results suggest an interaction between platelets and tumor aggressiveness. Thus, platelets serve as a novel, minimally invasive liquid biopsy for predicting outcome.

• 出版日期2017-10-27